Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana Bosch

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Science Signaling|March 27, 2014
Antagonism of EGFR and HER3 enhances the response to inhibitors of the PI3K-Akt pathway in triple-negative breast cancerJessica J Tao, Pau Castel, Nina Radosevic-Robin, et al.
Science Translational Medicine|April 17, 2015
PI3K inhibition results in enhanced estrogen receptor function and dependence in hormone receptor-positive breast cancerAna Bosch, Zhiqiang Li, Anna Bergamaschi, et al.
Obesity (Silver Spring, Md.)|August 16, 2014
Ambient temperature and prevalence of obesity in the Spanish population: The Di@bet.es studySergio Valdés, Cristina Maldonado-Araque, Francisca García-Torres, et al.
Eclinicalmedicine|August 2, 2023
The Lucerne Toolbox 2 to optimise axillary management for early breast cancer: a multidisciplinary expert consensusOrit Kaidar-Person, André Pfob, Oreste Davide Gentilini, et al.
Cancer Treatment Reviews|January 15, 2017
Strategies to design clinical studies to identify predictive biomarkers in cancer researchJose Luis Perez-Gracia, Miguel F Sanmamed, Ana Bosch, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Science Signaling|March 27, 2014
Antagonism of EGFR and HER3 enhances the response to inhibitors of the PI3K-Akt pathway in triple-negative breast cancerJessica J Tao, Pau Castel, Nina Radosevic-Robin, et al.
Science Translational Medicine|April 17, 2015
PI3K inhibition results in enhanced estrogen receptor function and dependence in hormone receptor-positive breast cancerAna Bosch, Zhiqiang Li, Anna Bergamaschi, et al.
Obesity (Silver Spring, Md.)|August 16, 2014
Ambient temperature and prevalence of obesity in the Spanish population: The Di@bet.es studySergio Valdés, Cristina Maldonado-Araque, Francisca García-Torres, et al.
Eclinicalmedicine|August 2, 2023
The Lucerne Toolbox 2 to optimise axillary management for early breast cancer: a multidisciplinary expert consensusOrit Kaidar-Person, André Pfob, Oreste Davide Gentilini, et al.
Cancer Treatment Reviews|January 15, 2017
Strategies to design clinical studies to identify predictive biomarkers in cancer researchJose Luis Perez-Gracia, Miguel F Sanmamed, Ana Bosch, et al.
Pageof 5